⌘K
Loading ticker…
As of 2026-08-24, Beam Therapeutics Inc. Common Stock (BEAM) has a 3-month relative strength percentile of 45 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.2%, relative volume 0.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
BEAM is in a stage 1 base, week 3. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.2% / 0.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BEAM is held by 25 ETFs as of May 2026. Top owner: VTWO at 0.09% weight, $16M notional. Top 3 carry $41M.
Held by 72 ETFs · $729M across latest filings · largest weight 5.43% (ARKG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.09% | $16M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.07% | $16M | — |
| VHTVanguard Health Care ETF | 0.05% | $9M | — |
| AVSC | 0.20% | $5M | +0.03 pp |
| VTWG | 0.18% | $3M | — |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $2M |
| — |
| GNOM | 3.09% | $2M | +0.88 pp |
| ESML | 0.06% | $1M | new |
| ONEQ | 0.01% | $1M | — |
| ESGV | 0.01% | $705K | — |
Showing 10 of 25 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BEAM Jan avg: 1.22% median: 2.08% win: 50% σ: 9.04% n: 4 2022-04-12 → 2026-07-31 | BEAM Feb avg: 14.78% median: 2.33% win: 75% σ: 31.71% n: 4 2022-04-12 → 2026-07-31 | BEAM Mar avg: -20.59% median: -20.12% win: 0% σ: 5.02% n: 4 2022-04-12 → 2026-07-31 | BEAM Apr avg: -5.92% median: 0.29% win: 60% σ: 24.50% n: 5 2022-04-12 → 2026-07-31 | BEAM May avg: -0.43% median: 3.88% win: 60% σ: 13.23% n: 5 2022-04-12 → 2026-07-31 | BEAM Jun avg: 4.03% median: 4.22% win: 80% σ: 4.88% n: 5 2022-04-12 → 2026-07-31 | BEAM Jul avg: 16.93% median: 15.87% win: 60% σ: 34.08% n: 5 2022-04-12 → 2026-07-31 | BEAM Aug avg: -17.72% median: -16.34% win: 0% σ: 5.03% n: 4 2022-04-12 → 2026-07-31 (current) | BEAM Sep avg: 7.80% median: -2.21% win: 50% σ: 27.92% n: 4 2022-04-12 → 2026-07-31 | BEAM Oct avg: -6.78% median: -9.04% win: 25% σ: 6.83% n: 4 2022-04-12 → 2026-07-31 | BEAM Nov avg: 15.97% median: 14.88% win: 100% σ: 15.32% n: 4 2022-04-12 → 2026-07-31 | BEAM Dec avg: -4.59% median: -6.23% win: 25% σ: 10.61% n: 4 2022-04-12 → 2026-07-31 |